Tigermed reports stable share capital and structure in October

Hangzhou Tigermed Consulting Co., Ltd. announced on November 3, 2025, that its statutory/registered share capital remained constant for the month ending October 31, 2025. The company's A-share statutory/registered share capital stood at RMB 737,901,250, with 737,901,250 A-shares at a par value of RMB 1 each. The H-share statutory/registered share capital also remained unchanged at RMB 123,124,800, representing 123,124,800 H-shares with a par value of RMB 1 each, bringing the total statutory/registered share capital to RMB 861,026,050.

The report further indicates that the number of issued A-shares (excluding treasury shares) was 732,017,470, with 5,883,780 A-shares held as treasury shares, totaling 737,901,250 issued A-shares. The number of issued H-shares was 123,124,800, with no H-shares held in treasury. There were no changes in either the issued shares or treasury shares for both A and H classes during October 2025.

The company previously noted share repurchases of A-shares totaling 1,168,700, 2,282,500, 204,000, 3,560,000, and 2,591,100 from May 2024 to February 2025. As of October 31, 2025, Tigermed held 5,883,780 A-shares as treasury stock after canceling 3,922,520 treasury shares on May 29, 2025.